Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide

Monir Moradzadeh Khiavi ¹, Ahamd Rostami ², Hamed Hamishekar ³, Mehran Mesgari Abassi ³, Amirala Aghbali ², Roya Salehi ³, Bita Abdollahi ³, Soheila Fotoohi ³, Mahmud Sina ²

Cited by CrossRef: 7

1- dos Santos Arruda F, Tomé F, Miguel M, de Menezes L, Nagib P, Campos E, Soave D, Celes M. Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game. CPD. 2019;25(2):109 [Crossref]

2- Alves J, Viana K, Pereira A, Lima Júnior R, Vale M, Pereira K, Gondim D. Oral carcinogenesis triggers a nociceptive behavior and c‐Fos expression in rats’ trigeminal pathway. Oral Diseases. 2023;29(4):1531 [Crossref]

3- Swidan S, Hassan M, Elmansy M, Swidan S. Synergistic therapeutic effect of nano-honokiol and 5-fluorouracil on the induced-tongue cancer in rats. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2020;32(6):556 [Crossref]

4- Pornpitchanarong C, Rojanarata T, Opanasopit P, Ngawhirunpat T, Patrojanasophon P. Catechol-modified chitosan/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells. Colloids and Surfaces B: Biointerfaces. 2020;196:111279 [Crossref]

5- Oballe H, Muniz F, Bueno C, Klein I, Carrard V, Rösing C, Gaio E. Spontaneous alveolar bone loss after 4NQO exposure in Wistar rats. Archives of Oral Biology. 2018;89:44 [Crossref]